Funded Startups in Tartumaa
In Tartumaa’s most recent 15 funded entries, the largest disclosed round is Icosagen Group’s $19M (2023-02-08), which sits far above the rest of the disclo…
In Tartumaa’s most recent 15 funded entries, the largest disclosed round is Icosagen Group’s $19M (2023-02-08), which sits far above the rest of the disclosed amounts: all other disclosed rounds are $3M or below, with the next step down appearing at $2M (Antegenes on 2022-08-02 and Remato on 2021-08-11). The only disclosed amounts near $3M are Solid World DAO at $3M (2022-05-03), while several materially smaller rounds cluster at $1M or under (e.g., Better Medicine $1M on 2025-08-14; Gearbox Biosciences $400K on 2023-10-13; Decomer Technology $100K on 2022-04-11).
The list is also sector-tilted toward Biotechnology: four entries are explicitly Biotechnology (Gearbox Biosciences, Icosagen Group, Decomer Technology, and Antegenes), with additional agriculture and software/tech categories filling out the remainder. Stage/amount disclosure is split between “undisclosed” (2 entries: eAgronom on 2025-05-08 and Viacurrent on 2024-08-09) and “Series Unknown” (3 entries: Menken Trials on 2024-06-17, KappaZeta on 2023-09-08, and Icosagen Group on 2023-02-08). Geographically, every row is based in Tartu, Tartumaa, and the dated window spans 2021-05-18 (LightCode Photonics) through 2025-08-14 (Better Medicine), with multiple recent Pre-Seed/Seed placements in 2023–2024.
Most recent rounds
15 shownRelated listings
Frequently asked
Which disclosed round is an outlier in Tartumaa, and how far above the next-largest disclosed amount it sits?
Icosagen Group’s $19M (2023-02-08) is the only disclosed round above $10M in this set, and it dwarfs the next-largest disclosed amounts at $3M (Solid World DAO on 2022-05-03) and $2M (Antegenes on 2022-08-02; Remato on 2021-08-11).
Are there any bursts of funding activity within a narrow time window, or is it spread evenly across years?
Rounds are concentrated in the 2021–2023 build-up and again in 2023–2025: multiple entries appear in 2023 (2023-02-08, 2023-09-08, 2023-10-13) and in 2024 (2024-06-17, 2024-08-09), with the most recent cluster extending into 2025 (Better Medicine on 2025-08-14 and eAgronom on 2025-05-08).
What share of the entries are Biotechnology, and which companies drive that concentration?
Biotechnology is the most frequent explicit sector in this list, appearing in 4 of 15 entries: Gearbox Biosciences ($400K on 2023-10-13), Icosagen Group ($19M on 2023-02-08), Decomer Technology ($100K on 2022-04-11), and Antegenes ($2M on 2022-08-02).
How common are missing or unspecified round sizes/stages (undisclosed amounts and Series Unknown), and where do they show up?
Undisclosed amounts occur in 2 entries (eAgronom on 2025-05-08; Viacurrent on 2024-08-09). Separately, “Series Unknown” appears in 3 entries (Menken Trials on 2024-06-17; KappaZeta on 2023-09-08; Icosagen Group on 2023-02-08).
Is Tartu the dominant geography across these rows, and does any entry deviate?
All 15 rows list Tartu, Tartumaa, Estonia as the location, so there is no geographic deviation within this subset.
Within the most recent entries by date, what stage pattern shows up, and which companies exemplify it?
The latest period includes several early-stage classifications: Better Medicine is Pre-Seed (2025-08-14) and GaltTec is Pre-Seed (2025-02-28). Seed and Pre-Seed also appear in 2024–2023 (e.g., Viacurrent is Seed on 2024-08-09; Gearbox Biosciences is Pre-Seed on 2023-10-13).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.